http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104761511-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c02c2577dd2151f9b00654a4b70e1ff3 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-26 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-26 |
filingDate | 2014-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e47fe3601c8518393dae741e4a069ceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4258a299a8f5cdb7d4618233ece97b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a89265b69c8295e697ca4336f70e03f6 |
publicationDate | 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104761511-A |
titleOfInvention | 2-hexadecyloxy-6-methyl-4H-3,1- benzoxazine-4-ketone crystal form and preparation method thereof |
abstract | The invention provides a 2-hexadecyloxy-6-methyl-4H-3,1- benzoxazine-4-ketone crystal form which is useful for the prevention and treatment of obesity. The invention relates to a2-hexadecyloxy-6-methyl-4H-3,1- benzoxazine-4-ketone crystal form, the powder X-ray diffraction of the crystal form has characteristic peaks at angle 2 theta of 7.4+/-0.2, 9.5+/-0.2, 11.1+/-0.2, 12.2+/-0.2, 14.7+/-0.22, 15.4+/-0.2, and 18.3+/-0.2. The invention also provides a preparation method of the crystal form. |
priorityDate | 2014-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.